Marta Tagliabue

Dr. Marta Tagliabue

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2013 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Closed access
PDF file
MAMohssen Ansarin
Mohssen Ansarin
SZStefano Zorzi
Stefano Zorzi
MMMaria Angela Massaro
Maria Angela Massaro
MTMarta Tagliabue
Marta Tagliabue
MPMichele Proh
Michele Proh
FCFausto Chiesa
Fausto Chiesa

24 March 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
MTMarta Tagliabue
Marta Tagliabue
PBPietro Belloni
Pietro Belloni
RBRita De Berardinis
Rita De Berardinis
SGSara Gandini
Sara Gandini
FCFrancesco Chu
Francesco Chu
MAMohssen Ansarin
Mohssen Ansarin
While evidence suggests an increasing incidence of tongue cancer in young adults, published findings regarding the prognostic role of age at diagnosis are inconsistent. We performed a meta‐analysis of the literature to highlight key points that might help in understanding the association between age of oral tongue cancer patients at diagnosis and their prognosis. According to age at diagnosis, a systematic literature review of all published cohort studies assessing the recurrence risks and mortality associated with tongue cancer was conducted. We compared the risk estimates between patients aged >45 years and those aged <45 years at diagnosis. Random‐effects models were used to calculate summary relative risk estimates (SRRs) according to different clinical outcomes and sources of between‐study heterogeneity (I2) and bias. We included 31 independent cohort studies published between 1989 and 2019; these studies included a total of 28,288 patients. When risk estimations were not adjusted for confounders, no significant association was found between age at diagnosis and overall survival (OS). Conversely, after adjustment for confounders, older age at diagnosis was associated with a significantly increased risk of mortality. The difference between SRRs for adjusted and unadjusted estimates was significant (p < 0.01). Younger patients had a significantly higher risk of local recurrence. Younger patients with oral tongue cancer have better OS but a greater risk of recurrence than older patients. These findings should be validated in a large prospective cohort study which considers all confounders and prognostic factors.

2 March 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Domenico MattoscioDomenico Mattoscio
Domenico Mattoscio
CCChiara Casadio
Chiara Casadio
CMClaudia Miccolo
Claudia Miccolo
FMFausto Maffini
Fausto Maffini
ARAndrea Raimondi
Andrea Raimondi
SCSusanna Chiocca
Susanna Chiocca
UBC9, the sole E2-conjugating enzyme required for SUMOylation, is a key regulator of essential cellular functions and, as such, is frequently altered in cancers. Along these lines, we recently reported that its expression gradually increases during early stages of human papillomavirus (HPV)-mediated cervical lesions transformation. However, a better understanding of how UBC9 is exploited by transforming viral oncoproteins is still needed. In the present study, we show that in human samples HPV drives UBC9 up-regulation also in very early steps of head and neck tumorigenesis, pointing to the important role for UBC9 in the HPV-mediated carcinogenic program. Moreover, using HPV-infected pre-cancerous tissues and primary human keratinocytes as the natural host of the virus, we investigate the pathological meaning and the cellular mechanisms responsible for UBC9 de-regulation in an oncoviral context. Our results show that UBC9 overexpression is promoted by transforming viral proteins to increase host cells’ resistance to apoptosis. In addition, ultrastuctural, pharmacological and genetic approaches crucially unveil that UBC9 is physiologically targeted by autophagy in human cells. However, the presence of HPV E6/E7 oncoproteins negatively impacts the autophagic process through selective inhibition of autophagosome-lysosome fusion, finally leading to p53 dependent UBC9 accumulation during viral-induced cellular transformation. Therefore, our study elucidates how UBC9 is manipulated by HPV oncoproteins, details the physiological mechanism by which UBC9 is degraded in cells, and identifies how HPV E6/E7 impact on autophagy. These findings point to UBC9 and autophagy as novel hallmarks of HPV oncogenesis, and open innovative avenues towards the treatment of HPV-related malignancies. High risk HPV is the primary cause of cervical cancer and in recent years a clear role for the virus in other anogenital malignancies, in head and neck and in nonmelanoma skin cancers is emerging. Cellular transformation is mediated by the viral oncoproteins E6 and E7 that have the ability to target several pathways. We recently demonstrated that UBC9, the key enzyme of the Small Ubiquitin-like Modifier (SUMO) pathway, is up-regulated during pre-cancerous and cancerous stages of cervical carcinogenesis. In this study, we elucidate the pathological impact and the cellular mechanisms responsible for UBC9 accumulation promoted by HPV in cervical and head and neck pre-cancerous tissues. Indeed, we show that UBC9 is physiologically degraded in cells by autophagy, and that the expression of HPV oncoproteins impairs autophagy finally leading to UBC9 accumulation and apoptosis resistance of infected cells. Our results therefore identify UBC9 and autophagy as important co-factors to prime early stages of HPV-mediated tumorigenesis, and pinpoint novel therapeutic strategies for treatment of carcinogenic HPV infections.

3 April 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MTMarta Tagliabue
Marta Tagliabue
Sara GandiniSara Gandini
Sara Gandini
FMFausto Maffini
Fausto Maffini
VNValeria Navach
Valeria Navach
RBRoberto Bruschini
Roberto Bruschini
MAMohssen Ansarin
Mohssen Ansarin

1 July 2017 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
FCFrancesco Chu
Francesco Chu
MTMarta Tagliabue
Marta Tagliabue
GGGioacchino Giugliano
Gioacchino Giugliano
LCLuca Calabrese
Luca Calabrese
LPLORENZO PREDA
LORENZO PREDA
MAMohssen Ansarin
Mohssen Ansarin

3 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
GPGiacomo Pietrobon
Giacomo Pietrobon
MTMarta Tagliabue
Marta Tagliabue
LSLuigi Marco Stringa
Luigi Marco Stringa
RBRita De Berardinis
Rita De Berardinis
FCFrancesco Chu
Francesco Chu
MAMohssen Ansarin
Mohssen Ansarin
We reviewed the current published literature on the impact of oral microbiota on oral cavity leukoplakia (OLK), aiming at clarifying its role in disease transformation. The analysis unveiled that bacterial richness and diversity in the oral cavity tend to be decreased in OLK compared to healthy controls, with a reduction in the prevalent commensals, such as Streptococci, and elevation of anaerobes. Moreover, Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia are recurrent findings, and they already have been linked to periodontal disease. These microbial community changes may also represent a marker for the transition from OLK to oral squamous cell carcinoma. Unfortunately, the reviewed studies present several limitations, making an objective comparison difficult. To overcome these biases, longitudinal studies are necessary.